Evidence map›Paper›PMID 28827342›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Human genetic variation in

Monica I Alvarez, Luke C Glover, Peter Luo, Liuyang Wang, Elizabeth Theusch, Stefan H Oehlers, Eric M Walton, Trinh Thi Bich Tram, Yu-Lin Kuang, Jerome I Rotter and 6 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. TheInfectious disorders drug targets · 2025
    Article
  4. Article
  5. FromACS omega · 2023
    Review
  6. Human variation impactingCell genomics · 2023
    Article
  7. Review
  8. Article
  9. Cells · 2022
    Article
  10. Integration of themBio · 2022
    Article
  11. Article
  12. Revisiting PersistentPathogens (Basel, Switzerland) · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. American Academy of Optometry Microbial Keratitis Think Tank.Optometry and vision science : official publication of the American Academy of Optometry · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Monica I AlvarezDepartment of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC 27710.
Luke C GloverDepartment of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC 27710.
Peter LuoDepartment of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC 27710.
Liuyang WangDepartment of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC 27710.
Elizabeth TheuschChildren's Hospital Oakland Research Institute, Oakland, CA 94609.
Stefan H OehlersDepartment of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC 27710.
Eric M WaltonDepartment of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC 27710.
Trinh Thi Bich TramOxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Yu-Lin KuangChildren's Hospital Oakland Research Institute, Oakland, CA 94609.
Jerome I RotterInstitute for Translational Genomics and Population Sciences, Los Angeles Biomedical Research Institute at Harbor-University of California, Los Angeles Medical Center, Torrance, CA 90502.
Colleen M McCleanDepartment of Immunology, School of Medicine, Duke University, Durham, NC 27710.
Nguyen Tran ChinhHospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Marisa W MedinaChildren's Hospital Oakland Research Institute, Oakland, CA 94609.
David M TobinDepartment of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC 27710.ORCID 0000-0003-3465-5518
Sarah J DunstanPeter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3010, Australia.
Dennis C KoDepartment of Molecular Genetics and Microbiology, School of Medicine, Duke University, Durham, NC 27710; dennis.ko@duke.edu.ORCID 0000-0002-0113-5981
Duke University · USHospital for Tropical Diseases · VNOxford University Clinical Research Unit · VNThe University of Melbourne · AUThe University of Sydney · AUUniversity of California, Los Angeles · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Andrea L Hevener · 2003 to 2026
$40.4M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
ORGANIZATION AND FUNCTIONS OF CELLULAR STRUCTUREST32GM007184 · NIGMS · DUKE UNIVERSITY · PI JINKS-ROBERTSON, SUE · 1985 to 2019
$18.2M
Pharmacogenomics of Statin TherapyP50GM115318 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RISCH, NEIL J. · 2015 to 2019
$14.0M
Pharmacogenomics and Risk of Cardiovascular DiseaseU19HL069757 · NHLBI · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI KRAUSS, RONALD M · 2010 to 2014
$12.8M
HUMAN GENETIC VARIATION REGULATING SALMONELLA HOST-PATHOGEN INTERACTIONS AND DISEASE SUSCEPTIBILITYR01AI118903 · NIAID · DUKE UNIVERSITY · PI KO, DENNIS CHUN-YONE · 2015 to 2024
$4.2M
Data commons for 'omic, microscopy and analysis core facilitiesS10OD018164 · OD · DUKE UNIVERSITY · PI WRAY, GREGORY A. · 2014 to 2014
$598k
Functional genomics of human variation to Salmonella invasionK22AI093595 · NIAID · DUKE UNIVERSITY · PI KO, DENNIS CHUN-YONE · 2012 to 2013
$262k
Role of Cholesterol Efflux Blockade in Mycobacterial Infection In VivoF30AI126693 · NIAID · DUKE UNIVERSITY · PI MCCLEAN, COLLEEN M · 2017 to 2019
$121k
NCATS NIH HHS UL1 TR001881NHLBI NIH HHS U19 HL069757NIAID NIH HHS F30 AI126693NIAID NIH HHS K22 AI093595NIAID NIH HHS R01 AI118903NIDDK NIH HHS P30 DK063491NIGMS NIH HHS P50 GM115318NIGMS NIH HHS T32 GM007171NIGMS NIH HHS T32 GM007184NIH HHS S10 OD018164Wellcome TrustWellcome Trust 089276/Z/09/Z
6 · The paper itself

Abstract

Risk, severity, and outcome of infection depend on the interplay of pathogen virulence and host susceptibility. Systematic identification of genetic susceptibility to infection is being undertaken through genome-wide association studies, but how to expeditiously move from genetic differences to functional mechanisms is unclear. Here, we use genetic association of molecular, cellular, and human disease traits and experimental validation to demonstrate that genetic variation affects expression of VAC14, a phosphoinositide-regulating protein, to influence susceptibility to

Indexed as

Cell Line, TumorCholesterolEzetimibeGenetic VariationGenome-Wide Association StudyHumansIntracellular Signaling Peptides and ProteinsMembrane ProteinsPolymorphism, Single NucleotideSalmonellaSalmonella typhiTyphoid FeverVirulenceCholesterolEzetimibeIntracellular Signaling Peptides and ProteinsMembrane ProteinsVAC14 protein, humanezetimibelymphoblastoid cell linephosphoinositideSalmonella pathogenicity island 1single nucleotide polymorphism

Identifiers

PMID28827342
PMCPMC5604016
OpenAlexW2747041325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.